Yüklüyor......
The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
N(6)-methyladenosine (m(6)A) has an important epitranscriptomic modification that controls cancer self-renewal and cell fate. The addition of m(6)A to mRNA is a reversible modification. The deposition of m(6)A is encoded by a methyltransferase complex involving three homologous factors, jargonized a...
Kaydedildi:
| Yayımlandı: | Mol Ther Oncolytics |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Gene & Cell Therapy
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256444/ https://ncbi.nlm.nih.gov/pubmed/32490170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.04.011 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|